Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response
Public ClinicalTrials.gov record NCT00285376. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo Controlled Study Assessing the Efficacy and Safety of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to determine the safety and effectiveness of vilazodone for major depressive disorder and to discover genetic markers associated with response. This study will enroll approximately 400 patients.
Study identification
- NCT ID
- NCT00285376
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 410 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2006 (Type not available)
- Primary completion
- May 2007 (Actual)
- Completion
- May 2007 (Actual)
- Last update posted
- Feb 21, 2008
2006 – 2007
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pharmacology Research Institute | Los Alamitos | California | 90720 | — |
| Pharmacology Research Institute | Newport Beach | California | 92660 | — |
| Pharmacology Research Institute | Northridge | California | 91324 | — |
| Pharmacology Research Institute | Riverside | California | 92506 | — |
| Atlanta Institute of Medicine & Research | Atlanta | Georgia | 30328 | — |
| Atlanta Institute of Medicine & Research | Marietta | Georgia | 30060 | — |
| Summit Research Network (Michigan), Inc. | Farmington Hills | Michigan | 48336 | — |
| Summit Research Network (Michigan), Inc. | Flint | Michigan | 48507 | — |
| Social Psychiatry Research Institute | Brooklyn | New York | 11235 | — |
| Summit Research Network (Oregon) Inc. | Portland | Oregon | 97210 | — |
| University of Pennsylvania Department of Psychiatry Mood and Anxiety Disorders Section | Philadelphia | Pennsylvania | 19104-3309 | — |
| Southeast Health Consultants, LLC | Charleston | South Carolina | 29407 | — |
| University of Utah health Services Center Dept. of Psychiatry Mood and Anxiety Disorders | Salt Lake City | Utah | 84132 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98004 | — |
| Summit Research Network (Seattle) LLC | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00285376, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2008 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00285376 live on ClinicalTrials.gov.